Clinical Research Directory
Browse clinical research sites, groups, and studies.
BS01 in Patients With Retinitis Pigmentosa
Sponsor: Bionic Sight LLC
Summary
A Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAG-ChronosFP) in Patients with Retinitis Pigmentosa
Official title: Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP in Patients With Retinitis Pigmentosa
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2020-02-06
Completion Date
2029-12-30
Last Updated
2026-01-23
Healthy Volunteers
No
Conditions
Interventions
BS01
Non-replicating, rep/cap-deleted, recombinant adeno-associated virus vector expressing an enhanced light-sensitive channelrhodopsin gene (ChronosFP)
Locations (1)
New Jersey Retina
Teaneck, New Jersey, United States